The role of ventriculoperitoneal shunting in patients with supratentorial glioma

por de la Fuente, Macarena I, DeAngelis, Lisa M
Publicado 2014

Erdheim-Chester disease among neuroinflammatory syndromes: the case for precision medicine

por de la Fuente, Macarena I., Rosenblum, Marc K., Diamond, Eli L., Tabar, Viviane S., Omuro, Antonio
Publicado 2020

Ivosidenib, an IDH1 inhibitor, in a patient with recurrent, IDH1-mutant glioblastoma: a case report from a Phase I study

por Tejera, Dalissa, Kushnirsky, Marina, Gultekin, Sakir H, Lu, Min, Steelman, Lori, de la Fuente, Macarena I
Publicado 2020

Simulated Adaptive Radiotherapy for Shrinking Glioblastoma Resection Cavities on a Hybrid MRI–Linear Accelerator

por Guevara, Beatriz, Cullison, Kaylie, Maziero, Danilo, Azzam, Gregory A., De La Fuente, Macarena I., Brown, Karen, Valderrama, Alessandro, Meshman, Jessica, Breto, Adrian, Ford, John Chetley, Mellon, Eric A.
Publicado 2023

Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imaging

por Bell, Jonathan B., Jin, William, Goryawala, Mohammed Z., Azzam, Gregory A., Abramowitz, Matthew C., Diwanji, Tejan, Ivan, Michael E., del Pilar Guillermo Prieto Eibl, Maria, de la Fuente, Macarena I., Mellon, Eric A.
Publicado 2023

A Deep Learning Approach for Automatic Segmentation during Daily MRI-Linac Radiotherapy of Glioblastoma

por Breto, Adrian L., Cullison, Kaylie, Zacharaki, Evangelia I., Wallaengen, Veronica, Maziero, Danilo, Jones, Kolton, Valderrama, Alessandro, de la Fuente, Macarena I., Meshman, Jessica, Azzam, Gregory A., Ford, John C., Stoyanova, Radka, Mellon, Eric A.
Publicado 2023

Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial

por de la Fuente, Macarena I, Colman, Howard, Rosenthal, Mark, Van Tine, Brian A, Levacic, Danijela, Walbert, Tobias, Gan, Hui K, Vieito, Maria, Milhem, Mohammed M, Lipford, Kathryn, Forsyth, Sanjeev, Guichard, Sylvie M, Mikhailov, Yelena, Sedkov, Alexander, Brevard, Julie, Kelly, Patrick F, Mohamed, Hesham, Monga, Varun
Publicado 2022

Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma

por Mellinghoff, Ingo K., Ellingson, Benjamin M., Touat, Mehdi, Maher, Elizabeth, De La Fuente, Macarena I., Holdhoff, Matthias, Cote, Gregory M., Burris, Howard, Janku, Filip, Young, Robert J., Huang, Raymond, Jiang, Liewen, Choe, Sung, Fan, Bin, Yen, Katharine, Lu, Min, Bowden, Chris, Steelman, Lori, Pandya, Shuchi S., Cloughesy, Timothy F., Wen, Patrick Y.
Publicado 2020

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

por Mellinghoff, Ingo K., Penas-Prado, Marta, Peters, Katherine B., Burris, Howard A., Maher, Elizabeth A., Janku, Filip, Cote, Gregory M., de la Fuente, Macarena I., Clarke, Jennifer L., Ellingson, Benjamin M., Chun, Saewon, Young, Robert J., Liu, Hua, Choe, Sung, Lu, Min, Le, Kha, Hassan, Islam, Steelman, Lori, Pandya, Shuchi S., Cloughesy, Timothy F., Wen, Patrick Y.
Publicado 2021